Historical Valuation
KALA BIO Inc (KALA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -1.45. The fair price of KALA BIO Inc (KALA) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：0.63
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
KALA BIO Inc (KALA) has a current Price-to-Book (P/B) ratio of -0.53. Compared to its 3-year average P/B ratio of 0.39 , the current P/B ratio is approximately -236.77% higher. Relative to its 5-year average P/B ratio of -0.03, the current P/B ratio is about 1998.69% higher. KALA BIO Inc (KALA) has a Forward Free Cash Flow (FCF) yield of approximately -481.93%. Compared to its 3-year average FCF yield of -170.23%, the current FCF yield is approximately 183.10% lower. Relative to its 5-year average FCF yield of -206.88% , the current FCF yield is about 132.95% lower.
P/B
Median3y
0.39
Median5y
-0.03
FCF Yield
Median3y
-170.23
Median5y
-206.88
Competitors Valuation Multiple
AI Analysis for KALA
The average P/S ratio for KALA competitors is 6.37, providing a benchmark for relative valuation. KALA BIO Inc Corp (KALA.O) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
AI Analysis for KALA
1Y
3Y
5Y
Market capitalization of KALA increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of KALA in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is KALA currently overvalued or undervalued?
KALA BIO Inc (KALA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -1.45. The fair price of KALA BIO Inc (KALA) is between NaN to NaN according to relative valuation methord.
What is KALA BIO Inc (KALA) fair value?
KALA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of KALA BIO Inc (KALA) is between NaN to NaN according to relative valuation methord.
How does KALA's valuation metrics compare to the industry average?
The average P/S ratio for KALA's competitors is 6.37, providing a benchmark for relative valuation. KALA BIO Inc Corp (KALA) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for KALA BIO Inc (KALA) as of Jan 10 2026?
As of Jan 10 2026, KALA BIO Inc (KALA) has a P/B ratio of -0.53. This indicates that the market values KALA at -0.53 times its book value.
What is the current FCF Yield for KALA BIO Inc (KALA) as of Jan 10 2026?
As of Jan 10 2026, KALA BIO Inc (KALA) has a FCF Yield of -481.93%. This means that for every dollar of KALA BIO Inc’s market capitalization, the company generates -481.93 cents in free cash flow.
What is the current Forward P/E ratio for KALA BIO Inc (KALA) as of Jan 10 2026?
As of Jan 10 2026, KALA BIO Inc (KALA) has a Forward P/E ratio of -0.85. This means the market is willing to pay $-0.85 for every dollar of KALA BIO Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for KALA BIO Inc (KALA) as of Jan 10 2026?
As of Jan 10 2026, KALA BIO Inc (KALA) has a Forward P/S ratio of 0.00. This means the market is valuing KALA at $0.00 for every dollar of expected revenue over the next 12 months.